Endo Stock News

DUBLIN, Jan. 25, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth–quarter and full-year 2021 financial results on February 28, 2022 and members of its senior mana

(Reuters) – Drugmaker Endo International plc said on Tuesday it had agreed to pay up to $65 million to resolve claims by the state of Florida and local governments that the drugmaker helped fuel the U.S. opioid epidemic.

Endo is to pay $63 million to Texas to settle claims made by the state and counties that the company was implicit in fueling the opioid crisis in the state.

DUBLIN, Dec. 23, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc., Endo Health Solutions Inc.

In last trading session, Endo International plc (NASDAQ:ENDP) saw 3.93 million shares changing hands with its beta currently measuring 1.16. Companys recent per share price level of $4.13 trading at $0.18 or 4.56% at ring of the bell on the day assigns it a market valuation of $945.94M. That closing price of ENDPs stock is Endo International plc (NASDAQ:ENDP) Is 53.03% Above Its 52-Week Low, But How Long Can It Continue? Read More »

(Reuters) -Endo International Plc has agreed to pay $63 million to resolve claims by the state of Texas and local governments that the drugmaker helped fuel the U.S. opioid epidemic, the state's attor

(RTTNews) - Endo International plc (ENDP) announced Thursday that its unit Endo Ventures Limited has entered into definitive agreements with SK Biopharmaceuticals for the development, registration, supply, commercialization and distribution of cenobamate on an exclusive basis in Canada. Paladin Labs Inc., an operating company of Endo, will be…

DUBLIN, Dec. 23, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with SK Biopharmaceutic…

Analysts expect that Endo International plc (NASDAQ:ENDP) (TSE:ENL) will post $0.66 earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have provided estimates for Endo Internationals earnings, with the highest EPS estimate coming in at $0.69 and the lowest estimate coming in at $0.62. Endo International posted earnings of $0.75 per share []

Endo International (NASDAQ:ENDP) (TSE:ENL) had its price target reduced by Barclays from $7.00 to $5.00 in a report issued on Thursday, Price Targets.com reports. Barclays currently has an equal weight rating on the stock. ENDP has been the subject of several other research reports. Zacks Investment Research raised shares of Endo International from a hold []

LOS ANGELES, United States: The report offers an all-inclusive and accurate research study on the global Renal Drugs market while chiefly focusing on current and historical market scenarios. Stakeholders, market players, investors, and other market participants can significantly benefit from the

Eagle Pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP's Vasostrict. This approval follows Eagle's courtroom win in a patent dispute with Endo several

Eagle Pharmaceuticals Inc said on Wednesday the U.S. health regulator approved its generic version of Endo Internationals blood pressure drug, Vasostrict, sending its shares to a more than one-month high. The U.S. Food and Drug Administrations approval comes just months after a Delaware federal court ruled that Eagles proposed generic, vasopressin, did not infringe on []

Endo International plc (NASDAQ:ENDP) with the stream of 1.17% also noticed, India Drive Shack Inc. (NYSE:DS) encountered a rapid change of 0.67% in the last hour of Wednesdays trading session. The post Heres What to Focus on: Endo International plc (NASDAQ:ENDP), Drive Shack Inc. (NYSE:DS) appeared first on Stocks Equity .